This record was last updated April 17, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to assess the effectiveness of a remote pharmacist intervention to help smokers quit.
The main questions it aims to answer are:
* Will smokers being screened for lung cancer with low-radiation-level chest computed tomography (CT) be willing to participate in this study and talk to the pharmacist about smoking cessation?
* Will those in the intervention group be more likely to report smoking cessation than those in the control group.
Participants in the intervention group will be asked to complete a baseline survey; speak with a pharmacist via phone call at baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks, and 12 weeks; and complete an exit survey.
Participants in the control group will be asked to complete a baseline survey and an exit survey.
Protocol Amendment History
2 changes
criticalTrial status changed: Enrolling by Invitation → Active, Not Recruiting2026-04-18